Endonovo Therapeutics (OTCMKTS:ENDV) Stock Soars After Announcing LOI to Acquire Specialty Construction Company
Over the course of the past weeks, the Endonovo Therapeutics (OTCMKTS:ENDV) stock has been in the middle of a major rally and it may now be a good time for investors to analyze the company a bit more closely. The rally in the stock continued on Thursday, as it ended the day with gains of as much as 20%, and that took the total gains generated over the course of…